ESETT

ESETT

The Established Status Epilepticus Treatment Trial

NCT01960075

|

1U01NS088034-01


Status: Completed

Overview


The Established Status Epilepticus Treatment Trial (ESETT) is a multicenter, randomized, double-blind, comparative effectiveness study of fos-phenytoin, levetiracetam, and valproic acid in subjects with benzodiazepine-refractory status epilepticus. Patients will be recruited by two national emergency research networks:  Neurology Emergency Treatment Trials (NETT) network and Pediatric Emergency Care and Applied Research Network (PECARN).  Each network has successfully undertaken a Status Epilepticus treatment trial under exception from informed consent (EFIC) rules. For more information on ESETT click on the Synopsis.

Contact


For general inquiries:

siren-contact@umich.edu

For a comprehensive list of contacts

Contact page on the SIREN website